Several pathways have been showed to activate NAD(P)H oxidase in Ang II-dependent or DOCA-salt–induced hypertension, including Ang II/AT1aR activation [39,41,65], direct PRR activation [29,39], and enhanced endothelin-1 signaling [66]. Here, FMO5 is linked to hypertensive disorder.